Insider trading

Period: 120 months Stock: AUPH Role: Other officers × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

53 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

53 decisions over 120 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

53 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

53 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
53 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
53 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

53 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
10 Sep 2026
Robertson Stephen P. Chief Legal Officer
Sold at will
$190.43K 11,939 at 15.95
2.0%
Not planned
21 Aug 2026
Robertson Stephen P. Chief Legal Officer
Sold at will
$355.95K 20,975 at 16.97
3.4%
Not planned
1 Aug 2025
Keenan Greg Chief Medical Officer
Sold at will
$210.00K 20,000 at 10.50
13.0%
Not planned
7 Mar 2025
Keenan Greg Chief Medical Officer
Sold at will
$68.35K 8,305 at 8.23
5.1%
Not planned
4 Mar 2025
Donley Matthew Maxwell Chief Operating Officer
Sold at will
$467.21K 58,991 at 7.92
8.0%
Not planned
4 Mar 2025
Robertson Stephen P. EVP, General Counsel
Sold at will
$456.25K 57,607 at 7.92
10.2%
Not planned
3 Mar 2025
Donley Matthew Maxwell Chief Operating Officer
Sold at will
$527.22K 65,902 at 8.00
8.2%
Not planned
3 Mar 2025
Robertson Stephen P. EVP, General Counsel
Sold at will
$518.98K 64,872 at 8.00
10.3%
Not planned
3 Mar 2025
Keenan Greg Chief Medical Officer
Sold at will
$97.91K 12,239 at 8.00
7.0%
Not planned
6 Aug 2024
Habig Scott Michael Chief Commercial Officer
Sold at will
$96.90K 18,249 at 5.31
3.8%
Not planned
6 Mar 2024
Robertson Stephen P. EVP, General Counsel
Sold at will
$323.37K 57,745 at 5.60
11.5%
Not planned
6 Mar 2024
Donley Matthew Maxwell EVP, Ops & Strategy
Sold at will
$224.06K 40,665 at 5.51
6.5%
Not planned
6 Mar 2024
Habig Scott Michael Chief Commercial Officer
Sold at will
$99.55K 17,777 at 5.60
3.6%
Not planned
27 Feb 2024
Knappertz Volker EVP, Research and Development
Sold at will
$30.07K 4,930 at 6.10
1.5%
Not planned
20 Feb 2024
Knappertz Volker EVP, Research and Development
Sold at will
$137.80K 25,146 at 5.48
7.2%
Not planned
20 Feb 2024
Habig Scott Michael Chief Commercial Officer
Sold at will
$86.95K 15,867 at 5.48
3.1%
Not planned
2 Mar 2023
Robertson Stephen P. EVP, General Counsel
Sold, plan not stated
$173.45K 19,402 at 8.94
6.0%
21 Nov 2022
Donley Matthew Maxwell Ex VP, Internal Operations
Bought
$46.60K 10,000 at 4.66
55.8%
+56% of stake
9 Nov 2022
Habig Scott Michael Chief Commercial Officer
Bought
$25.08K 5,000 at 5.02
opened
First buy on file
7 Nov 2022
Martin Michael Robert Chief Business Officer
Bought
$154.80K 30,000 at 5.16
50.4%
First buy on file
2 Mar 2022
Huizinga Robert Bindert EVP of Research
Sold, plan not stated
$58.24K 4,849 at 12.01
6.5%
2 Mar 2022
Martin Michael Robert Chief Business Officer
Sold, plan not stated
$58.24K 4,849 at 12.01
7.5%
2 Mar 2022
Solomons Neil Chief Medical Officer
Sold, plan not stated
$58.20K 4,846 at 12.01
5.1%
2 Mar 2022
Colao Massimilano Chief Commercial Officer
Sold, plan not stated
$38.49K 3,205 at 12.01
19.2%
2 Mar 2022
Donley Matthew Maxwell Ex VP, Intern'l Operations
Sold, plan not stated
$36.65K 3,052 at 12.01
15.8%
11 Nov 2021
Solomons Neil Chief Medical Officer
Sold, plan not stated
$2.89M 100,000 at 28.89
53.4%
Sold half or more
11 Nov 2021
Martin Michael Robert Chief Business Officer
Sold, plan not stated 2×
$1.16M 40,000 at 29.01
41.7%
10 Nov 2021
Solomons Neil Chief Medical Officer
Sold, plan not stated 2×
$3.11M 100,000 at 31.11
53.4%
Sold half or more
10 Nov 2021
Martin Michael Robert Chief Business Officer
Sold, plan not stated 2×
$1.87M 60,000 at 31.14
47.3%
9 Nov 2021
Solomons Neil Chief Medical Officer
Sold, plan not stated
$1.51M 50,000 at 30.17
36.4%
9 Nov 2021
Martin Michael Robert Chief Business Officer
Sold, plan not stated
$1.51M 50,000 at 30.17
28.3%
1 Nov 2021
Martin Michael Robert Chief Business Officer
Sold, plan not stated
$1.42M 45,000 at 31.64
20.3%
1 Nov 2021
Solomons Neil Chief Medical Officer
Sold, plan not stated
$1.42M 45,000 at 31.64
24.7%
25 Oct 2021
Huizinga Robert Bindert EVP of Research
Sold, plan not stated
$3.87M 130,000 at 29.75
66.4%
Sold half or more
21 Sep 2021
Martin Michael Robert Chief Business Officer
Sold, plan not stated
$2.10M 87,500 at 24.02
33.1%
21 Sep 2021
Huizinga Robert Bindert EVP of Research
Sold, plan not stated 2×
$779.53K 32,500 at 23.99
24.4%
20 Sep 2021
Martin Michael Robert Chief Business Officer
Sold, plan not stated 2×
$616.98K 28,500 at 21.65
13.9%
14 Sep 2021
Martin Michael Robert Chief Business Officer
Sold, plan not stated 3×
$2.87M 134,000 at 21.38
43.1%
14 Sep 2021
Huizinga Robert Bindert EVP of Research
Sold, plan not stated
$489.38K 22,500 at 21.75
17.5%
10 Sep 2021
Solomons Neil Chief Medical Officer
Sold, plan not stated
$2.98M 150,000 at 19.84
52.2%
Sold half or more
10 Sep 2021
Martin Michael Robert Chief Business Officer
Sold, plan not stated
$495.00K 25,000 at 19.80
12.4%
10 Sep 2021
Huizinga Robert Bindert EVP of Research
Sold, plan not stated 2×
$197.95K 10,000 at 19.80
7.2%
7 Sep 2021
Martin Michael Robert Chief Business Officer
Sold, plan not stated
$135.75K 7,500 at 18.10
4.1%
7 Sep 2021
Huizinga Robert Bindert EVP of Research
Sold, plan not stated
$91.50K 5,000 at 18.30
3.5%
26 Aug 2021
Martin Michael Robert Chief Business Officer
Sold, plan not stated
$400.73K 22,500 at 17.81
10.9%
25 Aug 2021
Solomons Neil Chief Medical Officer
Sold, plan not stated
$79.25K 5,000 at 15.85
3.5%
9 Aug 2021
Solomons Neil Chief Medical Officer
Sold, plan not stated
$721.35K 45,000 at 16.03
24.0%
9 Aug 2021
Martin Michael Robert Chief Business Officer
Sold, plan not stated
$80.05K 5,000 at 16.01
2.4%
28 Jul 2021
Martin Michael Robert Chief Business Officer
Sold, plan not stated
$69.30K 5,000 at 13.86
2.3%
22 Jun 2021
Martin Michael Robert Chief Business Officer
Sold, plan not stated
$68.80K 5,000 at 13.76
2.3%
Showing 1–50 of 53. Page 1 of 2 Older →